MarketPulse

GMP manufacturing

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

AsymBio Launches Conjugation Toolbox to Accelerate ADC Drug Development

AsymBio launches bioconjugate platform with 2-3 month IND timelines. Recognized at 2025 World ADC Awards amid expanding antibody-drug conjugate demand.
ASLTYCDMOGMP manufacturing
GlobeNewswire Inc.GlobeNewswire Inc.··Silexion Therapeutics Corp

Silexion Advances SIL204 Pancreatic Cancer Program With Manufacturing Deal, Ethics Approval

Silexion initiates GMP manufacturing of SIL204 siRNA therapy with Catalent and secures ethics approval for Phase 2/3 pancreatic cancer trial in Israel.
SLXNSLXNWregulatory approvalpancreatic cancer
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Curanex Advances Phyto-N Toward Late-Stage Development as Clinical Timeline Solidifies

Curanex advances Phyto-N toward IND submission in Q4 2026, completing manufacturing and toxicology milestones with secured 12-month funding.
CURXclinical trialspharmaceutical development